Christopher Carey, MD
Surgery · Oklahoma City, OKNPI 1770630659
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 62.4% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $17,686, more than ten times the $387 reported in 2019. Among surgery clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $277.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Intuitive Surgical$12K
- Stryker$2K
- Medtronic$150
- Innovation Technologies Inc$118
- Johnson & Johnson$104
- plus $202 from 6 others
What the payments were for
- Speaking & faculty fees$20,22552%
- Travel & lodging$8,70923%
- Food & beverage$4,14711%
- Education$5,50014%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 63 | $24,077 |
| Intuitive Surgical | 43 | $12,348 |
| Stryker | 14 | $1,595 |
| Medtronic(2 entities) | 2 | $150 |
| Innovation Technologies Inc | 2 | $118 |
| Johnson & Johnson(2 entities) | 4 | $104 |
| Davol Inc. | 3 | $55 |
| Acell, Inc. | 2 | $39 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| AstraZeneca | 1 | $21 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$22,632
- Da Vinci Surgical System$5,888
- DAVINCI XI$5,500
- CHROMOPHARE F300$1,098
- STRATTICE$275
- 1788$181
- N/A$181
- Endurant$114
How this compares
$38,595 in reported general payments places this provider in the 95th percentile of 290 surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 89 | $453 |
| Ondansetron Hcl | 12 | $66 |
| Levothyroxine Sodium | 17 | $52 |
| Tramadol Hcl | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other surgery in Oklahoma City
- Alexander RainesOklahoma City$36K
- Christopher HenryOklahoma City$16K
- Brian HerrittOklahoma City$12K
- Carson AgeeOklahoma City$11K
- Marcia MooreOklahoma City$11K
- Joseph BuendiaOklahoma City$11K
- Laura FischerOklahoma City$11K
- James ShepherdOklahoma City$10K
- Peter CollisterOklahoma City$10K
- Dayne JensenOklahoma City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.